Amino acids are the building blocks of protein synthesis. They are structural elements and
energy sources of cells necessary for normal cell growth, differentiation and function. Amino …

Metabolic dysfunction-associated fatty liver disease (MAFLD), proposed in 2020 is a novel
term for non-alcoholic fatty liver disease (NAFLD) which was coined for the first time in 1980 …

The development of liver fibrosis primarily determines quality of life as well as prognosis.
Animal models are often used to model and understand the underlying mechanisms of …

Background Non-alcoholic steatohepatitis (NASH), the progressive form of non-alcoholic
fatty liver disease (NAFLD), carries a high risk of cirrhosis and hepatocellular carcinoma …

Introduction Nonalcoholic steatohepatitis (NASH), also known as metabolic steatohepatitis,
is a clinical syndrome with pathological changes like alcoholic hepatitis but without a history …

Phenolic acids (PAs), a class of small bioactive molecules widely distributed in food and
mainly found as secondary plant metabolites, present significant advantages such as …

Hepatic fibrosis exacerbates mortality and complications in progressive metabolic
dysfunction-associated steatohepatitis (MASH). The role of the adenosine 2A receptor …

Infection with Schistosoma japonicum (S. japonicum) is an important zoonotic parasitic
disease that causes liver fibrosis in both human and domestic animals. The activation of …

LncRNAs are involved in modulating the individual risk and the severity of progression in
metabolic dysfunction-associated fatty liver disease (MASLD), but their precise roles remain …

Immune cells in the human lung are associated with idiopathic pulmonary fibrosis. However,
the contribution of different immune cell subpopulations to the pathogenesis of pulmonary …